Coherus Biosciences | CHRS

Stock Price
17.75
Daily Change
-1.72%
Yearly
-6.28%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
LG Chem 849,000.00 4,000.00 0.47% 116.58%
Fujifilm 8,734.00 -195.00 -2.18% 50.35%
AbbVie 118.85 1.98 1.69% 10.78%
Acadia Pharmaceuticals 18.79 -1.15 -5.77% -65.36%
Aerie Pharmaceuticals 10.22 -0.14 -1.35% -19.97%
Akebia Therapeutics 2.52 -0.15 -5.62% -18.18%
ALKERMES 22.04 -0.12 -0.54% 15.51%
Alnylam Pharmaceuticals 171.36 -11.49 -6.28% 32.26%
Alexion Pharmaceuticals 182.50 0 0% 70.54%
Amgen 202.44 1.27 0.63% -11.68%
Amarin 3.57 0 0% -28.74%
Baxter International 78.05 1.82 2.39% 0.06%
Biogen 223.92 -4.60 -2.01% -8.93%
Bluebird Bio 9.95 -0.68 -6.40% -78.79%
BioMarin Pharmaceutical 82.95 -1.73 -2.04% 4.20%
Bristol-Myers Squibb 56.32 0.91 1.64% -9.61%
Coherus Biosciences 17.75 -0.31 -1.72% -6.28%
Endo International Ordinary Shares 4.99 -0.29 -5.49% -7.25%
Gilead Sciences 69.56 -0.11 -0.16% 13.00%
Horizon Pharma 99.84 -3.89 -3.75% 39.21%
Ironwood Pharmaceuticals 10.98 -0.13 -1.17% -8.35%
Jazz Pharmaceuticals 120.35 -2.63 -2.14% -20.14%
Eli Lilly 245.58 -2.30 -0.93% 65.43%
Merck & Co 73.34 -0.55 -0.74% -10.50%
Myriad Genetics 24.38 -1.15 -4.50% 29.13%
Pacira 52.53 -1.22 -2.27% -13.33%
Pfizer 54.27 1.23 2.32% 34.53%
Perrigo 35.79 -0.04 -0.11% -28.23%
PTC Therapeutics 35.36 -1.75 -4.72% -46.19%
Regeneron Pharmaceuticals 635.16 1.16 0.18% 28.98%
Revance Therapeutics 14.60 -0.20 -1.35% -39.97%
Sarepta Therapeutics 78.50 -4.69 -5.64% -50.36%
Teva Pharmaceutical Industries Ltd 2,640.00 -40.00 -1.49% -16.75%
Vertex Pharmaceuticals 203.81 -0.64 -0.31% -10.73%
Xencor 35.16 -1.57 -4.27% -10.12%
Zoetis 223.33 0.14 0.06% 41.39%

Indexes Price Day Year
US400 2702 -35.15 -1.28% 20.37%
NASDAQ 15085 -295.85 -1.92% 21.03%

Coherus Biosciences
Coherus BioSciences, Inc. is a commercial stage biotherapeutics company. The Company is focused on the biosimilar and immuno-oncology market primarily in the United States. The Company’s pipeline includes the four categories product candidates, Oncology pipeline, Immunology pipeline, Ophthalmology pipeline and Small Molecule pipeline. Oncology pipeline includes Toripalimab, an anti-PD-1 antibody; UDENYCA (pegfilgrastim-cbqv); CHS-305, a bevacizumab (Avastin) biosimilar. Immunology pipeline includes CHS-1420, an anti-TNF product candidate, as an adalimumab (Humira) biosimilar. Ophthalmology pipeline includes CHS-201, a ranibizumab (Lucentis) biosimilar. CHS-201, a ranibizumab (Lucentis) biosimilar. Small Molecule pipeline includes CHS-131, an oral, small-molecule drug candidate. CHS-131 is a once-daily oral drug candidate for non-alcoholic steatohepatitis (NASH) and other metabolic conditions.